The aim of this multicenter study was to evaluate the technical and clinical performance of the Elecsys ® S100 electrochemiluminescence immunoassay and to assess its utility as a tumor marker in patients with malignant melanoma...
Keywords: Malignant melanoma, S100, tumor marker
05/2005 | Clinical Chemical Laboratory Medicine, Walter de GruyterKeywords: multiple trauma, primary brain damage, receiver-operating characteristics, S100, traumatic brain injury
09/2006 | Clinical Chemical Laboratory Medicine, Walter de Gruyter